beryllium has been researched along with Disease Models, Animal in 19 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 6 (31.58) | 18.7374 |
| 1990's | 5 (26.32) | 18.2507 |
| 2000's | 3 (15.79) | 29.6817 |
| 2010's | 3 (15.79) | 24.3611 |
| 2020's | 2 (10.53) | 2.80 |
| Authors | Studies |
|---|---|
| Atif, SM; Fontenot, AP; Mack, DG; Martin, AK | 1 |
| A Katouah, H; Acker, M; Al Hadi, R; Ali, M; Alserihi, R; Alyami, J; Alzahrani, E; Amirazodi, M; Amrillah, T; Andreassen, OA; Ardiccioni, C; Ask, H; Atzori, C; Ayorech, Z; Azambuja, JH; Azmi, R; Badem, S; Balci, AB; Bali, H; Baranova, NS; Barantsevich, ER; Barocci, S; Bauer, RJ; Bauermeister, JA; Bazhenova, TA; Biagetti, G; Bigdeli, F; Bonar, EE; Bouloumis, T; Bu, Y; Cai, Z; Cakiroglu, B; Canetto, SS; Cao, J; Caucci, S; Cerbo, I; Chen, C; Chen, J; Chen, Q; Chen, Y; Cheng, B; Cheng, X; Chinappi, M; Choya, A; Cicconardi, F; Cipolletta, S; Colasurdo, G; Costabile, BK; Coughlin, LN; Crippa, P; D'Agostino, M; D'Annessa, I; Daryanoosh, F; Das, R; Davey Smith, G; Davidson, BR; Davies, NM; Davis, TME; Davis, WA; de Rivas, B; Demir, D; Deng, Z; Dhanya, TM; Di Marino, D; Divya, KM; Dong, N; Drinkwater, JJ; Ekholuenetale, M; El-Bindary, AA; El-Bindary, MA; El-Desouky, MG; Elsayed, H; Ema, K; Endraswari, PD; Entilli, L; Ettl, T; Eyado, A; Fan, X; Fang, W; Farina, M; Florimbio, AR; Fowobaje, KR; Gaeini, A; Gao, XM; Gao, Y; Ghaemi, R; Ghelardi, E; Gilmutdinov, IF; Gochicoa-Rangel, L; Goncu, MT; Gözüküçük, R; Grammatikopoulos, P; Gu, Y; Guan, ZJ; Gucu, A; Guldberg, R; Gungor, O; Guo, W; Gutiérrez-Ortiz, JI; Guzmán-Boulloud, N; Guzmán-Valderrábano, C; Głuszko, A; Hama, A; Hamada, M; Han, J; Hashimoto, T; Havdahl, A; Hayashita, T; He, X; Helgeland, Ø; Hinck, AP; Hinck, CS; Holtzapple, M; Hou, Y; Howe, LD; Hu, B; Hu, H; Huang, L; Huang, Z; Hughes, AM; Hussain, G; Ibidoja, OJ; Ichikawa, D; Imber, C; Islam, MR; Iype, S; Jaber, J; Jacobs, R; Jafry, AT; Ji, L; Ji, X; Jiang, L; Jiang, Y; Jie, HFM; Jie, HM; Johansen, MP; Johansson, S; Juan, LX; Juan, W; Kahraman, N; Kallinger, I; Kang, H; Karakulova, YV; Kärmer, T; Kataoka, S; Kato, K; Kawashima, N; Kazim, AH; Khalil, MR; Kitazawa, H; Klimesova, YM; Kojima, S; Kose, M; Kostakis, ID; Koushkie Jahromi, M; Krishna, GA; Krizova, D; La Teana, A; Lan, K; Li, J; Li, JZ; Li, M; Li, R; Li, S; Li, Y; Li, Z; Liu, H; Liu, J; Liu, KG; Liu, L; Liu, Q; Liu, T; Liu, X; Lomachenko, KA; López-Fonseca, R; Ludwig, N; Luo, A; Luo, L; Luo, Y; Lupetti, A; M El-Metwaly, N; Ma, K; Maemura, R; Magnus, P; Manakin, YV; Mancia, F; Mashood, LO; Matsumoto, K; Mehrabi, A; Meier, JK; Mekonnen, Y; Mencarelli, D; Menzo, S; Mikagi, A; Mironov, VS; Misawa-Suzuki, T; Miwata, S; Mizuta, Y; Mohanan, PV; Mondal, J; Morici, P; Morita, K; Morozzo Della Rocca, B; Morris, T; Morsali, A; Morzhukhina, MV; Motta, S; Muramatsu, H; Naidu, R; Narita, A; Narita, K; Nasralla, D; Nemcokova, M; Netukova, M; Nishikawa, E; Nishio, N; Niu, X; Niu, Y; Njølstad, P; Notarstefano, V; Nugroho, MA; Nørgård, BM; Okuno, Y; Olokede, O; Ong, SP; Osailan, A; Ouyang, Z; Ozyazicioglu, AF; Pan, F; Parui, A; Paul, R; Pavoni, E; Payne, TE; Peng, X; Pérez-Padilla, R; Perta, N; Peter, SC; Pierantoni, L; Pietrowska, M; Pissanou, T; Pollok, JM; Prasetio, A; Putra, FS; Qiang, C; Qiao, L; Qutob, HMH; Raptis, DA; Razzo, BM; Reichborn-Kjennerud, T; Reichert, TE; Remigio-Luna, A; Rexha, J; Rivani, E; Rizzato, C; Romagnoli, A; Rossolini, GM; Sa, LY; Saad, RA; Sakaguchi, H; Salesi, M; Salsabilla, Z; Sanderson, E; Sanderson, P; Savitha, DP; Schulz, D; Seker, IB; Selvaganapathy, PR; Sha, D; Shah, SF; Shaikhomar, OA; Sharma, D; Shi, C; Shi, P; Shrotri, A; Sidiq, DH; Simonov, SV; Singh, AK; Song, C; Song, T; Spanier, G; Spoerl, S; Staropoli, A; Statsenko, ME; Steinhauer, S; Stosic, A; Studeny, P; Sugaya, T; Sun, S; Sun, X; Sunbul, SA; Supandi, AR; Suzuki, K; Suzuki, Y; Szczepański, MJ; Takahashi, Y; Taniguchi, R; Tao, Y; Tesli, M; Thirión-Romero, I; Tong, D; Trucchi, E; Tsuchido, Y; Turchetti, C; Turkina, SV; Turner, AW; Uldbjerg, N; Vinale, F; Wakamatsu, M; Walton, MA; Wang, C; Wang, Q; Wang, W; Wang, Y; Wang, Z; Wehberg, S; Wei, ZL; Wen, B; Whiteside, TL; Whittingham, MS; Widodo, ADW; Widłak, P; Wright, AI; Wu, H; Wu, Y; Wu, YL; Xiang, LG; Xiao, G; Xie, B; Xie, L; Xin, H; Xiong, J; Xiong, X; Xu, C; Xu, S; Yagubskii, EB; Yakushev, IA; Yang, H; Yang, J; Yao, J; Yao, ZX; Ye, J; Yerneni, SS; Yirgu, A; Yoshida, N; Yoshida, T; Young, SD; Yu, DN; Yuksel, A; Zac, J; Zac, S; Zarifkar, AH; Zhai, Y; Zhang, F; Zhang, H; Zhang, JW; Zhang, L; Zhang, Q; Zhang, X; Zhang, Y; Zhao, D; Zhao, J; Zhao, M; Zheng, D; Zheng, J; Zhou, G; Zhou, H; Zhu, P; Zhu, T; Zhu, Y; Zimmerman, MA; Zou, X | 1 |
| Crawford, F; Falta, MT; Fontenot, AP; Gordon, T; Hoover, MD; Kappler, JW; Mack, DG; Marrack, P; Martin, AK; McKee, AS; Mercer, RR; Simonian, PL; Tuder, RM | 1 |
| Crawford, F; Fontenot, AP; Mack, DG; McKee, AS | 1 |
| Bowerman, NA; Crawford, F; Falta, MT; Fontenot, AP; Kappler, JW; Mack, DG; Pinilla, C; Tinega, AN | 1 |
| Audusseau, S; Chevalier, G; L'espérance, G; Mazer, B; Muller, C; Plamondon, P; Salehi, F; Truchon, G; Zayed, J | 1 |
| Gordon, T; Nadas, A; Rubin, EM; Sorrentino, C; Tarantino-Hutchison, LM; Tinkle, SS; Weston, A; Zhu, Y | 1 |
| Leshukov, AV; Shin, RB; Urikh, AA | 1 |
| Barna, BP; Chiang, T; Deodhar, SD; Edinger, M; Gautam, S | 1 |
| Belinsky, SA; Finch, GL; Griffith, WC; Hahn, FF; Haley, PJ; Hoover, MD; Nikula, KJ | 1 |
| Hayes, RB | 1 |
| Komitowski, D | 1 |
| Auerbach, R; Huang, H; Kubai, L; Meyer, KC | 1 |
| Haley, PJ | 1 |
| Hiruma, T | 1 |
| Bice, DE; Finch, GL; Hahn, FF; Haley, PJ; Harmsen, AG; Hoover, MD; Mewhinney, JA; Muggenburg, BA | 1 |
| Barton, RW; Cole, SR; Gionfriddo, MA; McCormick, JR; Thrall, RS; Votto, JJ | 1 |
| Olekseeva, OG; Vasil'eva, EV | 1 |
| Burrell, R; Marx, JJ | 1 |
3 review(s) available for beryllium and Disease Models, Animal
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
The carcinogenicity of metals in humans.
Topics: Animals; Antimony; Arsenic; Beryllium; Cadmium; Carcinogens; Chemical Industry; Chromium; Cobalt; Disease Models, Animal; Environmental Exposure; Humans; Industry; Lead; Lung Neoplasms; Metals; Neoplasms; Neoplasms, Experimental; Nickel; Nose Neoplasms; Occupational Exposure; Risk Factors; Solubility | 1997 |
Mechanisms of granulomatous lung disease from inhaled beryllium: the role of antigenicity in granuloma formation.
Topics: Administration, Inhalation; Animals; Antigens; Berylliosis; Beryllium; Chronic Disease; Cytokines; Disease Models, Animal; Dogs; Granuloma; Humans; Lung Diseases; Rats | 1991 |
1 trial(s) available for beryllium and Disease Models, Animal
| Article | Year |
|---|---|
Impact of dexamethasone and tocilizumab on hematological parameters in COVID-19 patients with chronic disease.
Topics: Acetaminophen; Acetylcarnitine; Acetylcholinesterase; Acids; Acinetobacter baumannii; Acinetobacter Infections; Adaptation, Psychological; Adolescent; Adsorption; Adult; Aged; Alcohol Drinking; Alzheimer Disease; Amikacin; Ammonia; Anaerobiosis; Animals; Anorexia; Anti-Bacterial Agents; Anti-Infective Agents; Anti-Inflammatory Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Anxiety; Aptamers, Nucleotide; Asthenia; Attention Deficit Disorder with Hyperactivity; Bacterial Proteins; Beryllium; beta-Lactamases; Biofuels; Biomass; Biosensing Techniques; Bismuth; Blister; Body Mass Index; Body Surface Area; Boronic Acids; Brain; Breast Neoplasms; Butyrylcholinesterase; Cannabis; Carbapenems; Carbonyl Cyanide m-Chlorophenyl Hydrazone; Carboxylic Acids; Carcinoma, Hepatocellular; Cardiovascular Diseases; Carnitine; Case-Control Studies; Catalysis; Cell Cycle Proteins; Cell Line, Tumor; Cell Proliferation; Child; China; Cholinesterase Inhibitors; Clarithromycin; Clostridioides; Clostridioides difficile; Clostridium Infections; Cohort Studies; Colistin; Colitis; Colon; Coloring Agents; Coronary Artery Bypass; Creatinine; Crystalloid Solutions; Cytokines; Depression; Dextran Sulfate; Dextrans; Diabetes Mellitus, Type 2; Diabetic Retinopathy; Diarrhea; Dietary Supplements; Diphenhydramine; Disease Models, Animal; Disease Outbreaks; Double-Blind Method; Doxorubicin; Drosophila; Drug Tapering; Dysbiosis; Electrons; Escherichia coli; Extracellular Vesicles; Fatigue; Female; Fermentation; gamma-Cyclodextrins; Gastrointestinal Microbiome; Glucose; Graft Survival; Graft vs Host Disease; Head and Neck Neoplasms; Heart Arrest, Induced; Hematopoietic Stem Cell Transplantation; High-Intensity Interval Training; Hippocampus; Humans; Hydrogen-Ion Concentration; Hypertension; Incidence; Interferon-gamma; Italy; Kinetics; Klebsiella Infections; Klebsiella pneumoniae; Lab-On-A-Chip Devices; Lactoferrin; Larva; Length of Stay; Lignin; Liver; Liver Neoplasms; Liver Transplantation; Living Donors; Low Back Pain; Lung; Lung Volume Measurements; Macrophages; Male; Melphalan; Men; Mendelian Randomization Analysis; Meropenem; Methane; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Mitochondrial Proteins; Molecular Docking Simulation; Molecular Structure; Mothers; Motivation; Mycoplasma; Mycoplasma hominis; Mycoplasma Infections; NAD; Nanocomposites; Nanoparticles; Nanotubes, Carbon; Naproxen; Neovascularization, Pathologic; Neurons; Nitrates; Nucleolin; Opuntia; Paratyphoid Fever; Phenotype; Phosphatidylinositol 3-Kinases; Phytochemicals; Plant Extracts; Pregnancy; Prevalence; Prospective Studies; Proto-Oncogene Proteins c-akt; Pulmonary Disease, Chronic Obstructive; Rats; Rats, Wistar; Resveratrol; Retrospective Studies; Rifampin; Risk Factors; RNA, Messenger; Selenium; Sleep; Social Behavior; Soil; Soil Pollutants; Squamous Cell Carcinoma of Head and Neck; Staphylococcus aureus; Structure-Activity Relationship; Suicidal Ideation; Suicide; Superoxide Dismutase-1; Surveys and Questionnaires; Swimming; Syndrome; Tannins; Temperature; Transforming Growth Factor beta; Transplantation Conditioning; Treatment Outcome; Triple Negative Breast Neoplasms; Troponin T; Tumor Microenvironment; United Kingdom; Ureaplasma; Ureaplasma urealyticum; Urinary Tract Infections; Viscum; Waste Disposal Facilities; Wastewater; Water; Water Pollutants, Chemical; Wolfiporia; Young Adult | 2022 |
16 other study(ies) available for beryllium and Disease Models, Animal
| Article | Year |
|---|---|
Protective role of tissue-resident Tregs in a murine model of beryllium-induced disease.
Topics: Animals; Berylliosis; Beryllium; Disease Models, Animal; Inflammation; Lung Injury; Mice | 2022 |
Regulatory T cells modulate granulomatous inflammation in an HLA-DP2 transgenic murine model of beryllium-induced disease.
Topics: Adaptive Immunity; Animals; Berylliosis; Beryllium; Bronchoalveolar Lavage Fluid; CD4-Positive T-Lymphocytes; Disease Models, Animal; Enzyme-Linked Immunospot Assay; Flow Cytometry; Forkhead Transcription Factors; Granuloma; HLA-DP beta-Chains; Humans; Inflammation; Interferon-gamma; Interleukin-2; Lung; Mice; Mice, Transgenic; Spleen; T-Lymphocytes, Regulatory | 2014 |
MyD88 dependence of beryllium-induced dendritic cell trafficking and CD4⁺ T-cell priming.
Topics: Animals; Berylliosis; Beryllium; CD4-Positive T-Lymphocytes; Cell Movement; Dendritic Cells; Disease Models, Animal; Flow Cytometry; Humans; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myeloid Differentiation Factor 88; Neutrophils | 2015 |
Metal-specific CD4+ T-cell responses induced by beryllium exposure in HLA-DP2 transgenic mice.
Topics: Amino Acid Motifs; Animals; Berylliosis; Beryllium; CD4-Positive T-Lymphocytes; Disease Models, Animal; Epitope Mapping; Epitopes, T-Lymphocyte; Gene Expression; Genetic Predisposition to Disease; HLA-DP beta-Chains; Humans; Hybridomas; Lung; Mice; Mice, Transgenic; Molecular Sequence Data; Receptors, Antigen, T-Cell, alpha-beta; Static Electricity | 2016 |
Immunological responses in C3H/HeJ mice following nose-only inhalation exposure to different sizes of beryllium metal particles.
Topics: Administration, Inhalation; Animals; Beryllium; Bronchitis; Cell Proliferation; Cytokines; Disease Models, Animal; Flow Cytometry; Granuloma; Inhalation Exposure; Lung; Lymphocyte Activation; Lymphocytes; Male; Mice; Mice, Inbred Strains; Particle Size; Spleen | 2009 |
Genetic determinants of sensitivity to beryllium in mice.
Topics: Alleles; Animals; Berylliosis; Beryllium; Disease Models, Animal; Genetic Predisposition to Disease; HLA-DP Antigens; HLA-DP beta-Chains; Humans; Hypersensitivity, Delayed; Mice; Mice, Inbred Strains; Mice, Transgenic; Polymorphism, Genetic; Risk Factors; Skin Tests; Species Specificity; Th1 Cells | 2009 |
[Toxicologic characteristics of ammonium fluoroberyllate and its distribution in body after various intake methods].
Topics: Animals; Berylliosis; Beryllium; Disease Models, Animal; Drug Administration Routes; Fluorides; Male; Maximum Tolerated Dose; Occupational Diseases; Occupational Exposure; Quaternary Ammonium Compounds; Rats | 2006 |
Experimental beryllium-induced lung disease. I. Differences in immunologic responses to beryllium compounds in strains 2 and 13 guinea pigs.
Topics: Animals; Antibody Formation; Beryllium; Disease Models, Animal; Granuloma; Guinea Pigs; Humans; Lung Diseases; Lymphocyte Activation; Lymphokines; Male; Pulmonary Fibrosis; Skin Tests; Species Specificity | 1984 |
Animal models of beryllium-induced lung disease.
Topics: Animals; Beryllium; Disease Models, Animal; Dogs; Female; Granuloma; Humans; Lung Diseases; Lung Neoplasms; Macaca fascicularis; Male; Mice; Rats | 1996 |
Experimental bone tumors as models of human bone tumors.
Topics: Animals; Beryllium; Bone Neoplasms; Disease Models, Animal; Humans; Neoplasms, Experimental | 1979 |
An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells.
Topics: Animals; Antigens, Differentiation, Myelomonocytic; Beryllium; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Granuloma; Lung Diseases; Lymphocyte Subsets; Macrophage Activation; Mice; Mice, Inbred Strains; Time Factors | 1992 |
[Rabbit osteosarcoma induced by hydroxypropylcellulose mixed beryllium oxide pellet--comparison between implantations into bone marrow cavity and into fracture callus of the femur].
Topics: Alkaline Phosphatase; Animals; Beryllium; Biomarkers, Tumor; Bone Marrow; Bone Neoplasms; Bony Callus; Cellulose; Disease Models, Animal; Drug Implants; Femoral Fractures; Femur; Lung Neoplasms; Male; Osteosarcoma; Rabbits | 1991 |
A canine model of beryllium-induced granulomatous lung disease.
Topics: Aerosols; Animals; Berylliosis; Beryllium; Body Burden; Bronchoalveolar Lavage Fluid; Disease Models, Animal; Dogs; Female; Granuloma; Lung; Lymphocyte Activation; Lymphocytes; Male | 1989 |
A model of pulmonary granulomata induced by beryllium sulfate in the rat.
Topics: Animals; Berylliosis; Beryllium; Disease Models, Animal; Granuloma; Immunization; Lung; Lung Diseases; Lymphocytes; Male; Rats; Rats, Inbred F344; Specific Pathogen-Free Organisms; Therapeutic Irrigation | 1987 |
[Immunopathologic concept concerning the pathogenesis of berylliosis].
Topics: Animals; Autoimmune Diseases; Beryllium; Carcinogens; Disease Models, Animal; Humans; Occupational Diseases; Rats | 1972 |
Delayed hypersensitivity to beryllium compounds.
Topics: Animals; Beryllium; Cell Migration Inhibition; Cytotoxicity Tests, Immunologic; Disease Models, Animal; Drug Hypersensitivity; Guinea Pigs; Humans; Hypersensitivity, Delayed; Immunization, Passive; Injections, Intradermal; Injections, Intramuscular; Injections, Intraperitoneal; Leukocytes; Lung Diseases; Skin; Skin Tests; Tuberculin Test | 1973 |